ImmunoGen, Inc.Cambridge, MA, United States (NASDAQ (GM): IMGN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

Hoover's coverage by Patrice Sarath

ImmunoGen is TAPping into cancer research. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs...

Full Company Description for ImmunoGen

Headquarters:

128 Sidney St.
Cambridge, MA 02139
United States  (Map)

More ImmunoGen Locations & Contact Info

Key ImmunoGen Financials

Company Type Public - NASDAQ (GM): IMGN
Main Headquarters
Fiscal Year-End June
2008 Sales (mil.) $40.3
2006 Employees 192

More ImmunoGen Financials (11 pages)

Latest ImmunoGen Jobs jobs by Indeed

Competition

Competitive Landscape for Chemicals

Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...

Read more about ImmunoGen's competition across multiple industries

Top ImmunoGen Competitors

Editor-Selected Competitor List For ImmunoGen

ImmunoGen Executives

Title Name & Bio Contact
Chairman and CEO Mitchel (Mitch) Sayare Network | E-mail
President, COO, Acting CFO, and Director Daniel M. Junius Network | E-mail
Executive Director Investor Relations and Corporate Communications Carol Hausner Network | E-mail

More ImmunoGen Executives

Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.

Network With People At ImmunoGen

Tools from our advertising partners:

Sponsored Opportunity